Trials / Completed
CompletedNCT03934710
Mood Effects of Serotonin Agonists Extended
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.
Detailed description
Here, we are examining the effects of four repeated low doses of lysergic acid diethylamide (LSD), compared to placebo, administered to healthy adults at 3-4 day intervals, on mood, cognitive performance and responses to emotional tasks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Drug will be administered in solution form |
| DRUG | Serotonin agonist - 13ug | 13ug lysergic acid diethylamide |
| DRUG | Serotonin agonist - 26ug | 26ug lysergic acid diethylamide |
Timeline
- Start date
- 2019-04-20
- Primary completion
- 2021-06-07
- Completion
- 2021-06-07
- First posted
- 2019-05-02
- Last updated
- 2023-11-29
- Results posted
- 2023-11-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03934710. Inclusion in this directory is not an endorsement.